Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BNA Platform

K-Number: K202588 · 2020-12-07

ApplicantElminda, Ltd.
Decision Date2020-12-07
Product CodeOLU
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

BNA Platform is a medical device manufactured by Elminda, Ltd.. It received FDA 510(k) clearance on 2020-12-07 under approval number K202588. The device is classified under product code OLU. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BNA Platform?

BNA Platform is a medical device that received FDA 510(k) clearance on 2020-12-07. It is manufactured by Elminda, Ltd.. The 510(k) number is K202588.

When was BNA Platform approved by the FDA?

BNA Platform received FDA 510(k) clearance on 2020-12-07, under approval number K202588.

What company makes BNA Platform?

BNA Platform is manufactured by Elminda, Ltd..

What is the FDA product code for BNA Platform?

The FDA product code for BNA Platform is OLU.

Related Devices (Code: OLU)

K171414qEEG-ProBrainmaster Technologies, Inc. K191432cortiQ PROG.Tec Medical Engineering GmbH K222838iSyncBrain©-CiMediSync, Inc. K212684BrainView QEEG SoftwareMedeia, Inc. K240420NeuroField Analysis SuiteNeurofield, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑